Jacobsen Capital Management Raises Holdings in Intuitive Surgical, Inc. $ISRG

Jacobsen Capital Management lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 615 shares of the medical equipment provider’s stock after purchasing an additional 37 shares during the quarter. Jacobsen Capital Management’s holdings in Intuitive Surgical were worth $334,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC raised its holdings in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Intuitive Surgical by 9.3% during the first quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider’s stock valued at $3,029,000 after buying an additional 518 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in shares of Intuitive Surgical by 4.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 32,747 shares of the medical equipment provider’s stock valued at $16,219,000 after acquiring an additional 1,480 shares during the period. Flagship Harbor Advisors LLC raised its stake in Intuitive Surgical by 4.8% in the 1st quarter. Flagship Harbor Advisors LLC now owns 3,316 shares of the medical equipment provider’s stock worth $1,642,000 after acquiring an additional 151 shares during the last quarter. Finally, Oppenheimer & Co. Inc. raised its stake in Intuitive Surgical by 13.7% in the 1st quarter. Oppenheimer & Co. Inc. now owns 20,223 shares of the medical equipment provider’s stock worth $10,016,000 after acquiring an additional 2,438 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ISRG has been the topic of several research analyst reports. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Evercore ISI decreased their price objective on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research note on Tuesday, October 7th. Fifteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $585.05.

Intuitive Surgical Trading Up 0.9%

Shares of ISRG stock opened at $462.74 on Wednesday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market cap of $165.88 billion, a P/E ratio of 64.54, a P/E/G ratio of 4.81 and a beta of 1.61. The stock has a 50 day moving average of $454.39 and a 200 day moving average of $495.58.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue was up 22.9% on a year-over-year basis. During the same quarter last year, the company earned $1.84 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.